NEO
Neogenomics Inc
Price:  
14.24 
USD
Volume:  
519,454.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NEO WACC - Weighted Average Cost of Capital

The WACC of Neogenomics Inc (NEO) is 7.2%.

The Cost of Equity of Neogenomics Inc (NEO) is 8.20%.
The Cost of Debt of Neogenomics Inc (NEO) is 5.50%.

Range Selected
Cost of equity 6.80% - 9.60% 8.20%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 4.00% - 7.00% 5.50%
WACC 5.9% - 8.6% 7.2%
WACC

NEO WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.63 0.84
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.80% 9.60%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.3 0.3
Cost of debt 4.00% 7.00%
After-tax WACC 5.9% 8.6%
Selected WACC 7.2%